Patents by Inventor Andreas Kyas

Andreas Kyas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PURIFIED CARDIOGENIN ISOMER AND RELATED METHODS
    Publication number: 20160207869
    Abstract: A cardiogenin major isomer is obtained from a methanol extract of Geum japonicum and separated from its minor isomer. The separation of the two isomers can be achieved by chiral phase chromatography, e.g., using a Chiralpak® IC™ column. The purity of the isolated cardiogenin major isomer can be further increased by crystallization, yielding isolated cardiogenin major isomer having HPLC purity as high as 98.97% (a/a) at 210 nm and a potency of 95.50%) (w/w).
    Type: Application
    Filed: August 28, 2015
    Publication date: July 21, 2016
    Inventors: Andreas KYAS, Ernst FREUND, Oliver SCHLÖRKE, Joerg LILL, Lars ROGALL, Dario MENIA, Gary ELLIOTT, James PATERNITI
  • Sulfonic acid salts of heterocyclylamide-substituted imidazoles
    Patent number: 9133165
    Abstract: The invention relates to sulfonic acid salts of heterocyclylamide-substituted imidazoles, and to solvates and hydrates thereof, to the use thereof for treating and/or preventing diseases, and to use thereof for producing drugs for treating and/or preventing diseases, in particular for use as antiviral agents, in particular against cytomegaloviruses.
    Type: Grant
    Filed: September 12, 2012
    Date of Patent: September 15, 2015
    Assignee: AICURIS GMBH & CO. KG
    Inventors: Wilfried Schwab, Guido Schiffer, Kurt Voegtli, Andreas Kyas, Gerd Osswald
  • SULFONIC ACID SALTS OF HETEROCYCLYLAMIDE-SUBSTITUTED IMIDAZOLES
    Publication number: 20140315924
    Abstract: The invention relates to sulfonic acid salts of heterocyclylamide-substituted imidazoles, and to solvates and hydrates thereof, to the use thereof for treating and/or preventing diseases, and to use thereof for producing drugs for treating and/or preventing diseases, in particular for use as antiviral agents, in particular against cytomegaloviruses.
    Type: Application
    Filed: September 12, 2012
    Publication date: October 23, 2014
    Applicant: AICURIS GMBH & CO. KG
    Inventors: Wilfried Schwab, Guido Schiffer, Kurt Voegtli, Andreas Kyas, Gerd Osswald
  • PURIFIED CARDIOGENIN ISOMER AND RELATED METHODS
    Publication number: 20130345159
    Abstract: A cardiogenin major isomer is obtained from a methanol extract of Geum japonicum and separated from its minor isomer. The separation of the two isomers can be achieved by chiral phase chromatography, e.g., using a Chiralpak® IC™ column. The purity of the isolated cardiogenin major isomer can be further increased by crystallization, yielding isolated cardiogenin major isomer having HPLC purity as high as 98.97% (a/a) at 210 nm and a potency of 95.50%) (w/w).
    Type: Application
    Filed: December 21, 2011
    Publication date: December 26, 2013
    Applicant: HUYA BIOSCIENCE INTERNATIONAL LLC
    Inventors: Andreas Kyas, Ernst Freund, Oliver Schlörke, Joerg Lill, Lars Rogall, Dario Menia, Gary Elliott, James Paterniti